Seth R Freeman from GlassRatner Advisory & Capital Group notes the market’s reaction to Trump’s tariff threats and concerns about AI advancements. There is uncertainty about immediate tariffs, particularly with Colombia, raising worries in the commodities market. Freeman highlights the potential impact on tech workers and data centers due to AI developments like DeepSeek.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected
January 30, 2025